Wolverine Trading
NYMX

Wolverine Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Wolverine Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,200
Closed -$33K – 7231
2021
Q2 		$33K Buy
+21,200
New +$39.3K ﹤0.01% 5657
2020
Q3 		– Sell
-11,700
Closed -$41K – 5349
2020
Q2 		$41K Sell
11,700
-4,100
-26% -$13K ﹤0.01% 4346
2020
Q1 		$34K Buy
+15,800
New +$44.3K ﹤0.01% 4349
2019
Q3 		– Sell
-11,300
Closed -$16K – 5218
2019
Q2 		$16K Sell
11,300
-700
-6% -$1.23K ﹤0.01% 4298
2019
Q1 		$24K Buy
+12,000
New +$25.5K ﹤0.01% 4392
2018
Q3 		– Sell
-37,400
Closed -$158K – 6149
2018
Q2 		$158K Hold
37,400
– – ﹤0.01% 4538
2018
Q1 		$158K Buy
37,400
+2,500
+7% +$8.66K ﹤0.01% 4538
2017
Q4 		$115K Sell
34,900
-5,700
-14% -$20.8K ﹤0.01% 4410
2017
Q3 		$155K Sell
40,600
-6,000
-13% -$22.8K ﹤0.01% 3927
2017
Q2 		$214K Buy
46,600
+27,200
+140% +$112K ﹤0.01% 3514
2017
Q1 		$72K Buy
+19,400
New +$63.8K ﹤0.01% 3920

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's NYMX Position: Q4 2020 in Review

Wolverine Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2020, closing a stake of 10,534 shares — an estimated $27K sold.

Wolverine Trading first reported a position in NYMX in Q2 2017 and held it in 11 quarters. The position peaked at $272K in Q3 2017. 58 funds tracked by Wall St. Rank hold NYMX as of Q4 2020.

  • Wolverine Trading reported no remaining Nymox Pharmaceutical Corp position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,534 Nymox Pharmaceutical Corp shares in Q4 2020, an estimated $27K.
  • Wolverine Trading first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 11 quarters.
  • Wolverine Trading's Nymox Pharmaceutical Corp position peaked at $272K in Q3 2017.
  • 58 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.